158 related articles for article (PubMed ID: 33121952)
1. Morphine and myocardial ischaemia-reperfusion.
Wu LN; Hu R; Yu JM
Eur J Pharmacol; 2021 Jan; 891():173683. PubMed ID: 33121952
[TBL] [Abstract][Full Text] [Related]
2. Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.
Hausenloy DJ; Garcia-Dorado D; Bøtker HE; Davidson SM; Downey J; Engel FB; Jennings R; Lecour S; Leor J; Madonna R; Ovize M; Perrino C; Prunier F; Schulz R; Sluijter JPG; Van Laake LW; Vinten-Johansen J; Yellon DM; Ytrehus K; Heusch G; Ferdinandy P
Cardiovasc Res; 2017 May; 113(6):564-585. PubMed ID: 28453734
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Role of mPTP in Ischemia-Reperfusion Injury.
Morciano G; Bonora M; Campo G; Aquila G; Rizzo P; Giorgi C; Wieckowski MR; Pinton P
Adv Exp Med Biol; 2017; 982():169-189. PubMed ID: 28551787
[TBL] [Abstract][Full Text] [Related]
4. Innate immunity as a target for acute cardioprotection.
Zuurbier CJ; Abbate A; Cabrera-Fuentes HA; Cohen MV; Collino M; De Kleijn DPV; Downey JM; Pagliaro P; Preissner KT; Takahashi M; Davidson SM
Cardiovasc Res; 2019 Jun; 115(7):1131-1142. PubMed ID: 30576455
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis kinetics at reperfusion period in patients with acute ST-Segment Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention and treated with thrombolytic therapy.
Gultekin N; Bulut G; Kucukates E; Yildiz A; Kocas C; Bulut L
J Pak Med Assoc; 2016 Jul; 66(7):808-14. PubMed ID: 27427127
[TBL] [Abstract][Full Text] [Related]
6. Reducing myocardial infarct size: challenges and future opportunities.
Bulluck H; Yellon DM; Hausenloy DJ
Heart; 2016 Mar; 102(5):341-8. PubMed ID: 26674987
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.
Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244
[TBL] [Abstract][Full Text] [Related]
8. Effect and Safety of Morphine Use in Acute Anterior ST-Segment Elevation Myocardial Infarction.
Bonin M; Mewton N; Roubille F; Morel O; Cayla G; Angoulvant D; Elbaz M; Claeys MJ; Garcia-Dorado D; Giraud C; Rioufol G; Jossan C; Ovize M; Guerin P;
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440010
[TBL] [Abstract][Full Text] [Related]
9. Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope.
He J; Bellenger NG; Ludman AJ; Shore AC; Strain WD
Rev Cardiovasc Med; 2022 Jan; 23(1):23. PubMed ID: 35092215
[TBL] [Abstract][Full Text] [Related]
10. The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction.
Hortmann M; Robinson S; Mohr M; Mauler M; Stallmann D; Reinöhl J; Duerschmied D; Peter K; Carr J; Gibson CM; Bode C; Ahrens I
Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):695-702. PubMed ID: 28534645
[TBL] [Abstract][Full Text] [Related]
11. Effect of remote ischemic preconditioning in patients with STEMI during primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Chen E; Cai W; Hu D; Chen L
Rev Cardiovasc Med; 2020 Mar; 21(1):103-112. PubMed ID: 32259908
[TBL] [Abstract][Full Text] [Related]
12. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial.
Le Corvoisier P; Gallet R; Lesault PF; Audureau E; Paul M; Ternacle J; Ghostine S; Champagne S; Arrouasse R; Bitari D; Mouillet G; Dubois-Randé JL; Berdeaux A; Ghaleh B; Deux JF; Teiger E
BMC Cardiovasc Disord; 2018 Oct; 18(1):193. PubMed ID: 30340532
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry.
Bainey KR; Armstrong PW; Zheng Y; Brass N; Tyrrell BD; Leung R; Westerhout CM; Welsh RC
Circ Cardiovasc Interv; 2019 Oct; 12(10):e008059. PubMed ID: 31607152
[TBL] [Abstract][Full Text] [Related]
14. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.
Haig C; Carrick D; Carberry J; Mangion K; Maznyczka A; Wetherall K; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Hood S; Watkins S; Davie A; Mahrous A; Mordi I; Ahmed N; Teng Yue May V; Ford I; Radjenovic A; Welsh P; Sattar N; Oldroyd KG; Berry C
JACC Cardiovasc Imaging; 2019 Jun; 12(6):993-1003. PubMed ID: 30031700
[TBL] [Abstract][Full Text] [Related]
15. Remote Ischemic Perconditioning to Reduce Reperfusion Injury During Acute ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.
McLeod SL; Iansavichene A; Cheskes S
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515120
[TBL] [Abstract][Full Text] [Related]
16. Myocardial reperfusion injury: looking beyond primary PCI.
Fröhlich GM; Meier P; White SK; Yellon DM; Hausenloy DJ
Eur Heart J; 2013 Jun; 34(23):1714-22. PubMed ID: 23536610
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
18. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
Heusch G; Gersh BJ
Eur Heart J; 2017 Mar; 38(11):774-784. PubMed ID: 27354052
[TBL] [Abstract][Full Text] [Related]
19. Trimetazidine in the Prevention of Tissue Ischemic Conditions.
Kallistratos MS; Poulimenos LE; Giannitsi S; Tsinivizov P; Manolis AJ
Angiology; 2019 Apr; 70(4):291-298. PubMed ID: 29888611
[TBL] [Abstract][Full Text] [Related]
20. Influence of preinfarction angina and coronary collateral blood flow on the efficacy of remote ischaemic conditioning in patients with ST segment elevation myocardial infarction: post hoc subgroup analysis of a randomised controlled trial.
Pryds K; Bøttcher M; Sloth AD; Munk K; Rahbek Schmidt M; Bøtker HE;
BMJ Open; 2016 Nov; 6(11):e013314. PubMed ID: 27884851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
